Have questions about tesamorelin?
Text us: +1 (972) 919-0219
Research Use Only
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Tesamorelin is a synthetic peptide that functions as a growth hormone–releasing hormone (GHRH) analog. In laboratory research, it is studied for its ability to stimulate growth hormone secretion and is of interest in investigations involving endocrine signaling and metabolic pathways.
Certificate of Analysis
Frequently asked questions
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), designed to stimulate the release of endogenous growth hormone. In preclinical and clinical research, it has been studied for its ability to enhance GH and IGF-1 secretion, regulate metabolic pathways, and support investigations into endocrine signaling.
Tesamorelin was developed through research into GHRH peptides, building on discoveries that synthetic analogs could prolong the half-life and activity of native GHRH fragments. It was synthesized in the late 1990s and early 2000s as a stabilized peptide with improved pharmacokinetic properties, allowing for sustained GH release in experimental models. Research expanded into its effects on metabolic regulation and endocrine function, where it has remained an important tool in laboratory and clinical studies.
Tesamorelin Structure
CAS #: 218949-48-5
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: ~5135.9 g/mol
PubChem ID: 16132314
Tesamorelin has been studied in endocrine, metabolic, and molecular models, with research highlighting its activity in growth hormone release, IGF-1 signaling, metabolism, and protein synthesis pathways. Studies also report effects on lipid and glucose metabolism, insulin sensitivity, and cellular proliferation in preclinical systems.
Key Areas of Research:
• Endocrine: GH, IGF-1, metabolism
• Metabolic: lipid, glucose, insulin sensitivity
• Cellular: proliferation, repair, protein synthesis
Together, these findings suggest broad experimental potential for Tesamorelin across endocrine, metabolic, and cellular pathways. By modulating GH and IGF-1 signaling and influencing metabolic and protein synthesis processes, Tesamorelin provides a versatile research platform for exploring tissue repair, metabolic regulation, and growth biology in laboratory models.
